Euclidean Capital LLC Q2 2025 Filing
Filed August 14, 2025
Portfolio Value
$305.7B
Holdings
11
Report Date
Q2 2025
Filing Type
13F-HR
All Holdings (11 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | VEUVANGUARD INTL EQUITY INDEX F | 2,142,684 | $144.0B | 47.11% | |
| 2 | INDAISHARES TR | 2,425,144 | $135.0B | 44.17% | |
| 3 | ORICORIC PHARMACEUTICALS INC | 989,410 | $10.0B | 3.28% | |
| 4 | FHTXFOGHORN THERAPEUTICS INC | 1,573,761 | $7.4B | 2.42% | |
| 5 | PMVPPMV PHARMACEUTICALS INC | 2,627,643 | $2.8B | 0.91% | |
| 6 | SPYSPDR S&P 500 ETF TR | 4,104 | $2.5B | 0.83% | |
| 7 | ALECALECTOR INC | 1,307,858 | $1.8B | 0.60% | |
| 8 | SRZNSURROZEN INC | 87,696 | $784.0M | 0.26% | |
| 9 | RAPTRAPT THERAPEUTICS INC | 82,234 | $657.9M | 0.22% | |
| 10 | TNYATENAYA THERAPEUTICS INC | 1,015,705 | $620.8M | 0.20% | |
| 11 | SRZNWSURROZEN INC | 170,833 | $3.1M | 0.00% |